Sensus Healthcare, Inc. — fact timeline

Sensus Healthcare, Inc. entered into Loan Agreement with City National Bank of Florida valued at $15,000,000 (effective 2026-06-02).

“On June 2, 2026, Sensus Healthcare, Inc. (the "Company") entered into a Loan Agreement (the "Loan Agreement") with City National Bank of Florida ("CNB") pursuant to which CNB has made available to the Company a revolving credit facility providing for maximum borrowings of $15,000,000”

Sensus Healthcare, Inc. shareholders approved Auditor Appointment Ratification at the 2026-05-29 meeting.

“3. Auditor Appointment Ratification . Stockholders ratified the appointment of Carr, Riggs & Ingram, LLC as the Company’s independent registered public accountant for the fiscal year ended December 31, 2026. The tabulation of votes cast was as follows: For Against Abstention 10,738,792 148,466 432,715”

Sensus Healthcare, Inc. shareholders approved Advisory Vote on Executive Compensation at the 2026-05-29 meeting.

“2. Advisory Vote on Executive Compensation . Stockholders approved, on a non-binding advisory basis, the compensation of the Company’s named executive officers for 2025. The tabulation of votes cast was as follows: For Against Abstention Broker Non-Votes 4,740,572 856,128 722,554 5,000,719”

Sensus Healthcare, Inc. shareholders approved Election of Directors at the 2026-05-29 meeting.

“1. Election of Directors . Eric Sachetta and Michael J. Sardano were elected as Class II directors for a three-year term to expire in 2029. Each nominee was an incumbent director, and no other person was nominated. The tabulation of votes cast was as follows: For Against Abstention Broker Non-Votes Eric Sachetta 5,532,247 516,567 270,440 5,000,719 Michael J. Sardano 4,702,852 1,346,063 270,339 5,000,719”

Sensus Healthcare, Inc. reported the three months ended March 31, 2026 results: revenue $3.4 million.

“and non-oncological skin conditions, today announced financial results and business highlights for the three months ended March 31, 2026. Highlights included: ● Revenue of $3.4 million compared to $8.3 million for the three months ended March 31, 2025. o Excluding sales to the Company’s historically largest customer, revenue increased from $2.7 million in the”

Sensus Healthcare, Inc. engaged Carr, Riggs & Ingram, LLC as its auditor.

“(the “Company”) was notified that Carr, Riggs & Ingram, LLC (“CRI”) acquired, effective as of January 1, 2026, certain assets related to the capital markets practice of Berkowitz Pollack Brant Advisors + CPAs, LLP (“BPB”). On January 13, 2026, the Audit Committee of the Company’s Board of Directors simultaneously dismissed BPB as the Company’s independent registered public accounting firm and approved the appointment of CRI as the Company’s independent registered public accounting firm.”

Sensus Healthcare, Inc. dismissed Berkowitz Pollack Brant Advisors + CPAs, LLP as its auditor.

“cquired, effective as of January 1, 2026, certain assets related to the capital markets practice of Berkowitz Pollack Brant Advisors + CPAs, LLP (“BPB”). On January 13, 2026, the Audit Committee of the Company’s Board of Directors simultaneously dismissed BPB as the Company’s independent registered public accounting firm and approved the appointment of CRI as the Company’s independent”

John Heinrich resigned as Director at Sensus Healthcare, Inc..

“Dr. Heinrich’s decision to resign”

Sensus Healthcare, Inc. reported the three months ended March 31, 2024 results: revenue $10.7 million, net income $2.3 million, or $0.14 per diluted share, EPS $0.14 per diluted share.

“Sensus Healthcare Reports First Quarter 2024 Financial Results With Revenues up More than Three-fold · Revenues of $10.7 million, compared with $3.4 million in the prior-year quarter”